CD4+ cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients

International Journal of Infectious Diseases

Volumn 15, Issue 12, 2011, Pages

  Bordon, Jose ^a,b   Kapoor, Rama ^b   Martinez, Cesar ^c   Portela, Daniel ^c   Duvvuri, Padmaraj ^a   Klochko, Alyona ^d   Ayesu, Kwabena ^d   Peyrani, Paula ^b   Cillóniz, Catia ^e   Wiemken, Timothy ^b   Parra, Ana ^f   Torres, Antoni ^e   Rello, Jordi ^f   Ramirez, Julio ^b  

^a Providence Hospital Washington DC   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF BARCELONA   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

CD4+ cell counts; Clinical outcomes; Community acquired pneumonia; HIV RNA level

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; VIRUS RNA;

ADENOVIRUS; ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VIRUS A H1N1; LEGIONELLA; LENGTH OF STAY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME; TIME TO CLINICAL STABILITY;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, BACTERIAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RNA, VIRAL; SPAIN; UNITED STATES;

EID: 82455199096     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.05.021     Document Type: Article

References (24)

1. Feikin D.R., Feldman C., Schuchat A., Janoff E.N. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004, 4:445-455.
2. Gilks C.F., Brindle R.J., Otieno L.S., Simani P.M., Newnham R.S., Bhatt S.M., et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990, 336:545-549.
3. Rodríguez-Créixems M., Muñoz P., Miranda E., Peláez T., Alonso R., Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med 1996, 156:1429-1434.
4. Hirschtick R.E., Glassroth J., Jordan M.C., Wilcosky T.C., Wallace J.M., Kvale P.A., et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995, 28:333. 845-51.
5. Kohli R., Lo Y., Homel P., Flanigan T.P., Gardner L.I., Howard A.A., et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis 2006, 43:90-98.
6. Corbett E.L., Churchyard G.J., Charalambos S., Samb B., Moloi V., Clayton T.C., et al. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 2002, 34:1251-1258.
7. Walson J.L., Brown E.R., Otieno P.A., Mbori-Ngacha D.A., Wariua G., Obimbo E.M., et al. Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up. J Acquir Immune Defic Syndr 2007, 46:208-215.
8. Jordano Q., Falco V., Almirante B., Planes A.M., del Valle O., Ribera E., et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004, 38:1623-1628.
9. Christensen D., Feldman C., Rossi P., Marrie T., Blasi F., Luna C., et al. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis 2005, 41:554-556.
10. Malinis M., Myers J., Bordon J., Peyrani P., Kapoor R., Nakamatzu R., et al. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis 2010, 14:e22-e27.
11. Curran A., Falco V., Crespo M., Martinez X., Ribera E., Villar del Saz S., et al. Bacterial pneumonia in HIV-infected patients: use of pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 2008, 9:609-615.
12. Feldman C., Klugman K.P., Yu V.L., Ortqvist A., Choiu C.C., Chedid M.B., et al. International Pneumococcal Study Group. Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect 2007, 55:125-135.
13. Polsky B., Gold J.W., Whimbey E., Dryjanski J., Brown A.E., Schiffman G., et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986, 104:38-41.
14. Floris-Moore M., Lo Y., Klein R.S., Budner N., Gourevitch M.N., Moskaleva G., et al. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003, 34:331-337.
15. Sogaard O.S., Lohse N., Gerstoft J., Kronborg G., Ostergaard L., Pedersen C., et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis 2008, 47:1345-1353.
16. Gordin F.M., Roediger M.P., Girard P.M., Lundgren J.D., Miro J.M., Palfreeman A., et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008, 178:630-636.
17. Mandell L., Wunderink R., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72.
18. Ramirez J.A. Fostering international multi center collaborative research: the CAPO project. Int J Tuberc Lung Dis 2007, 11:1062-1065.
19. Ewig S., de roux A., Bauer T., García E., Mensa J., Niederman M., et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004, 50:421-427.
20. Cohn D.L. Bacterial pneumonia in the HIV-infected patient. Infect Dis Clin North Am 1991, 5:485-507.
21. Daley C.L. Bacterial pneumonia in HIV-infected patients. Semin Respir Infect 1993, 8:104-115.
22. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., Fauci A.S., et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983, 309:453-458.
23. Perelló R., Miró O., Miró J., Moreno A. Role of the eosinophil count in discriminating the severity of community-acquired pneumonia in HIV-infected patients. Crit Care 2008, 12:425.
24. Cowburn A.S., Condliffe A.M., Farahi N., Summers C., Chilvers E.R. Advances in neutrophil biology: clinical implications. Chest 2008, 134:606-612.